The current financial score of Insmed Inc is 8.80. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 425.49M, representing a year-over-year increase of 296.11%, while its net profit experienced a year-over-year increase of 95.88%.
The current valuation score of Insmed Inc is 9.34. Its current P/E ratio is -20.85, which is -81.93% below the recent high of -3.77 and -64.16% above the recent low of -34.23.
The current earnings forecast score of Insmed Inc is 8.58. The average price target is 199.70, with a high of 243.00 and a low of 169.00.
The current price momentum score of Insmed Inc is 3.43. Currently, the stock price is trading between the resistance level at 128.17 and the support level at 114.49, making it suitable for range-bound swing trading.
The current institutional shareholding score of Insmed Inc is 10.00. The latest institutional shareholding proportion is 104.47%, representing a quarter-over-quarter increase of 0.02%. The largest institutional shareholder is Joel Greenblatt, holding a total of 21.89K shares, representing 0.01% of shares outstanding, with 60.71% decrease in holdings.
The current risk assessment score of Insmed Inc is 4.72. The company's beta value is 0.81. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.